Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat

3 days ago · Get The Latest GMAB Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. ... Genmab A/S (GMAB) Stock Price, News & Analysis $21.18-0.48 (-2.22%) (As of 03:40 PM ET) Add. Compare. Share. ... Only 5 people have searched for …

CouponFollow Extension

22%
OFF

Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat

1 week from now

marketbeat.com

$45.20
OFF

Genmab A/S (GMAB) Stock Forecast And Price Target 2024

1 week from now

6 days ago · According to the 10 analysts' twelve-month price targets for Genmab A/S, the average price target is $45.20. The highest price target for GMAB is $50.00, while the lowest …

marketbeat.com

$22.78
OFF

Genmab A/S (GMAB) Stock Chart And Price History 2024

1 week from now

3 days ago · Enter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 11/05/2024 $22.78

marketbeat.com

$22.57
OFF

Genmab A/S (NASDAQ:GMAB) Receives Average Rating Of

1 week from now

Oct 31, 2024 · Read Our Latest Research Report on Genmab A/S Genmab A/S Price Performance. Shares of GMAB stock opened at $22.57 on Thursday. The stock has a market …

marketbeat.com

$23.08
OFF

Leerink Partnrs Forecasts Increased Earnings For Genmab A/S

1 week from now

6 days ago · Get Our Latest Research Report on GMAB. Genmab A/S Stock Down 0.1 %. Shares of NASDAQ:GMAB opened at $23.08 on Monday. The firm has a market capitalization of …

defenseworld.net

$46.00
OFF

Genmab A/S (NASDAQ:GMAB) Sees Unusually-High Trading …

1 week from now

Oct 21, 2024 · Several research firms recently commented on GMAB. BTIG Research raised their price objective on shares of Genmab A/S from $46.00 to $47.00 and gave the stock a "buy" …

marketbeat.com

$631.91
OFF

Genmab A/S (GMAB) Earnings Date And Reports 2024 - MarketBeat

1 week from now

2 days ago · Genmab A/S (NASDAQ:GMAB) has a recorded net income of $631.91 million. ... Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 19.99 and a forward …

marketbeat.com

11%
OFF

AbbVie Stock Falls 11% In A Month: Should You Buy The Dip?

1 week from now

2 days ago · ABBV’s stock crashed on the news, making investors wonder if they should sell the stock. ... AbbVie Inc. (ABBV) : Free Stock Analysis Report. Genmab A/S Sponsored ADR …

nasdaq.com

$45.20
OFF

Genmab A/S's (GMAB) Buy Rating Reiterated At HC Wainwright

1 week from now

Oct 16, 2024 · Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $45.20. View Our Latest Stock …

marketbeat.com

$24.39
OFF

Genmab A/S FY2024 EPS Estimate Increased By Leerink Partnrs

1 week from now

6 days ago · The firm has a fifty day moving average price of $24.39 and a 200-day moving average price of $26.38. Genmab A/S has a 12 month low of $21.90 and a 12 month high of …

marketbeat.com

$932000
OFF

Crossmark Global Holdings Inc. Has $932,000 Stake In

1 week from now

2 days ago · Get Our Latest Report on GMAB Genmab A/S Price Performance. Genmab A/S stock opened at $21.18 on Friday. The business has a 50 day moving average of $24.08 and …

marketbeat.com

$14.77
OFF

Genmab A/S (NASDAQ:GMAB) Reaches New 1-Year Low

1 week from now

Oct 31, 2024 · Get Our Latest Research Report on Genmab A/S. Genmab A/S Stock Performance. The stock has a market capitalization of $14.77 billion, a PE ratio of 18.65, a …

marketbeat.com

FAQs about Genmab A/S (GMAB) Stock Price, News & Analysis - MarketBeat Coupon?

Should you buy Genmab A/S (GMB)?

Investors should be bearish about investing in Genmab A/S for these reasons: The stock has been trading down recently, showing a 1.0% decrease, which may raise concerns about short-term performance. Genmab A/S has a beta of 0.97, suggesting that the stock's price is closely correlated with market movements, potentially leading to higher volatility. ...

Is Genmab A good stock to buy?

Recent price target updates from analysts suggest a potential upside of 76.37% from the current stock price, providing a growth opportunity for investors. Institutional investors have been increasing their stakes in Genmab A/S, indicating confidence in the company's future prospects. ...

How many shares does gmab a/s (gmab) have?

Purchases Shares of 5,607 Genmab A/S (NASDAQ:GMAB) Sign up to receive the latest news and ratings for GMAB and its competitors with MarketBeat's FREE daily newsletter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ...

Is Genmab A/S Stock overvalued?

The company's P/E ratio of 23.58 may indicate that the stock is currently overvalued compared to its earnings, posing a risk for investors. Genmab A/S has a 1-year high of $39.81, which could signal resistance at higher price levels and limit potential short-term gains for investors. ...

Will Genmab increase its share capital?

Company Announcement COPENHAGEN, Denmark; September 10, 2024 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 11,729 shares as a consequence of the exercise of employee warrants. The inc... ...

Where can I buy gmab stock?

Shares of GMAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. ...